ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹522 Cr | ₹531 Cr | ₹129 Cr | ₹144 Cr | ₹287 Cr |
What is the latest Net Current Assets ratio of ORCHID PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹531 Cr |
| Mar2023 | ₹129 Cr |
| Mar2022 | ₹144 Cr |
| Mar2021 | ₹287 Cr |
How is Net Current Assets of ORCHID PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -1.70 | |
| Mar2024 | ₹531 Cr | 311.08 | |
| Mar2023 | ₹129 Cr | -10.07 | |
| Mar2022 | ₹144 Cr | -49.96 | |
| Mar2021 | ₹287 Cr | - | |
Compare Net Current Assets of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,418.2 Cr | -3.1% | -14.8% | -48.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -3.1% |
-14.8% |
-48.4% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses